OpenClinica vs Veeva EDC(EDC)

Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.

Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.

Guide updated How we compare

Compare within EDC

Study fit, side by side

These notes describe the products in the EDC guide.

OpenClinica

Best for
Academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.
What to consider
OpenClinica is the only commercial EDC here with public list prices, and it documents an ODM-based REST API. It has fewer native modules than the enterprise suites, and Everest Group rated it a Major Contender, not a Leader, in 2024.
Read product profile

Veeva EDC

Best for
Sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
What to consider
Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full EDC feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

OpenClinica vs Veeva EDC (EDC): category feature evidence and sources. Products are not ranked.
Category featureOpenClinicaVeeva EDC
Track record in regulated multi-site trials
Feature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Supported

OpenClinica says its technology has powered over 15,000 studies and more than three million patients.

Source
Supported

Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.

Source
Study build and mid-study changes
Feature definitions
Supported
Study setup or post-go-live study changes are described.
Extended support
Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Supported

OpenClinica offers drag-and-drop self-build with CDASH templates or a free expert-managed build, but does not publicly document how amendments deploy.

Source
About this support label

Self-build and managed build are stated; amendment deployment is not documented.

Supported

Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.

Source
About this support label

Amendments avoid system shutdown, but deployment includes a brief casebook lockout.

Compliance and security
Feature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Supported

OpenClinica states 21 CFR Part 11, ICH GCP, HIPAA and GDPR compliance and lists SOC 2 Type II and ISO 27001 certification.

Source
About this support label

Trial standards and ISO/SOC claims are stated; public certificate or report access is not established.

Supported

Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.

Source
About this support label

Part 11 eSignature and ISO/SOC statements are given; public certificate or report access is not established.

Platform breadth
Feature definitions
Supported
EDC connects to another named clinical-trial module.
Extended support
Native randomization, trial supply management, medical coding, and either eCOA or ePRO are documented alongside EDC.
Supported

OpenClinica lists EDC with eConsent, eCOA, randomization, EHR-to-EDC and reporting; it has no native trial supply management or coding.

Source
About this support label

eConsent, eCOA and randomization establish base support despite the stated absence of native supply and coding.

Supported

Veeva's clinical data suite lists EDC, eCOA, RTSM (randomization and supply) and DQS data management, and Veeva also sells CTMS and eConsent.

Source
About this support label

Connected clinical applications are listed; native medical coding is not established in this note.

APIs and data standards
Feature definitions
Supported
An API for clinical data exchange is stated.
Extended support
An API plus data exchange in a named CDISC format are documented.
Extended support

OpenClinica documents a REST API that imports and retrieves clinical data as CDISC ODM 1.3.2 XML or JSON, and it offers EHR-to-EDC.

Source
About this support label

The REST API imports and retrieves clinical data in CDISC ODM.

Supported

Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.

Source
About this support label

The API uses an ODM-like model; the only stated ODM export is legacy.

Published pricing and terms
Feature definitions
Supported
A pricing basis, model or contract terms are published beyond contact sales.
Extended support
Production prices or a free production option are published, with amounts and conditions stated.
Extended support

OpenClinica publishes prices: EDC-only Launch at $750 a month with a 30-day free trial, and Core at $3,000 a month per study on a 12-month contract.

Source
About this support label

Monthly production prices and the per-study contract term are published.

Unknown

Veeva publishes no EDC prices or pricing model.

Source
About this support label

The note finds neither published prices nor a pricing model.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the EDC guide using the same feature definitions.

More EDC comparisons featuring one of these products.